T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.31B |
| 2 |
Home Depot
HD
|
+$1.07B |
| 3 |
Alibaba
BABA
|
+$1.06B |
| 4 |
Yum! Brands
YUM
|
+$887M |
| 5 |
Honeywell
HON
|
+$860M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
N
Netsuite Inc
N
|
+$1.59B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.33B |
| 3 |
Danaher
DHR
|
+$1.13B |
| 4 |
HBI
Hanesbrands
HBI
|
+$1.06B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$845M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.86% |
| 2 | Healthcare | 16.8% |
| 3 | Consumer Discretionary | 15.02% |
| 4 | Technology | 13.29% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
26
DELISTED
Walgreens Boots Alliance
WBA
| $3.16B | 0.63% |
38,176,666
-1,142,740
| -3% | -$94.5M |
|
27
O'Reilly Automotive
ORLY
$74.9B
| $2.98B | 0.59% |
160,597,770
+41,138,760
| +34% | +$751M |
|
28
State Street
STT
$51.4B
| $2.9B | 0.58% |
37,302,018
-234,955
| -0.6% | -$17.7M |
|
|
MRSH
29
Marsh
MRSH
$91.3B
| $2.88B | 0.57% |
42,591,647
-8,054,985
| -16% | -$540M |
|
30
American Tower
AMT
$79B
| $2.86B | 0.57% |
27,021,800
-1,719,962
| -6% | -$187M |
|
31
Intercontinental Exchange
ICE
$84.9B
| $2.77B | 0.55% |
49,039,159
+439,634
| +0.9% | +$24.3M |
|
32
PG&E
PCG
$38.1B
| $2.76B | 0.55% |
45,480,173
-260,541
| -0.6% | -$15.6M |
|
|
BNY
33
Bank of New York Mellon
BNY
$109B
| $2.76B | 0.55% |
58,208,764
-1,727,825
| -3% | -$77.9M |
|
|
AMTD
34
DELISTED
TD Ameritrade Holding Corp
AMTD
| $2.69B | 0.53% |
61,651,067
-3,663,490
| -6% | -$142M |
|
35
Pfizer
PFE
$152B
| $2.63B | 0.52% |
85,269,803
-13,086,713
| -13% | -$400M |
|
36
Roper Technologies
ROP
$39.5B
| $2.6B | 0.52% |
14,226,654
+7,799
| +0.1% | +$1.4M |
|
|
ALXN
37
DELISTED
Alexion Pharmaceuticals
ALXN
| $2.58B | 0.51% |
21,087,420
+1,722,986
| +9% | +$211M |
|
38
GE Aerospace
GE
$382B
| $2.56B | 0.51% |
16,936,857
-900,136
| -5% | -$131M |
|
39
Tesla
TSLA
$1.31T
| $2.54B | 0.5% |
178,490,145
+40,729,275
| +30% | +$535M |
|
40
Becton Dickinson
BDX
$49.4B
| $2.53B | 0.5% |
15,682,549
-1,587,007
| -9% | -$263M |
|
41
Biogen
BIIB
$30.1B
| $2.47B | 0.49% |
8,718,233
+1,108,205
| +15% | +$329M |
|
|
42
Home Depot
HD
$353B
| $2.46B | 0.49% |
18,316,086
+8,308,311
| +83% | +$1.07B |
|
43
Comcast
CMCSA
$91B
| $2.44B | 0.48% |
70,534,742
-17,049,368
| -19% | -$569M |
|
|
44
Thermo Fisher Scientific
TMO
$224B
| $2.43B | 0.48% |
17,227,446
-5,729,417
| -25% | -$845M |
|
45
AutoZone
AZO
$49.7B
| $2.41B | 0.48% |
3,047,550
-290,969
| -9% | -$224M |
|
46
Stryker
SYK
$134B
| $2.37B | 0.47% |
19,789,230
+2,286,136
| +13% | +$263M |
|
47
Lowe's Companies
LOW
$124B
| $2.33B | 0.46% |
32,787,201
-10,881,710
| -25% | -$770M |
|
48
Citigroup
C
$228B
| $2.31B | 0.46% |
38,949,452
-3,563,326
| -8% | -$192M |
|
49
Merck
MRK
$322B
| $2.22B | 0.44% |
39,469,352
+2,089,229
| +6% | +$122M |
|
50
Zoetis
ZTS
$31.1B
| $2.21B | 0.44% |
41,237,906
+6,374,524
| +18% | +$324M |
|
Similar funds
T. Rowe Price Associates's Q4 2016 Portfolio in Review
As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
- T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
- T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
- T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
- T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
- T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.
Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.